Medical genetics company Invitae has collaborated with The Outer Banks Hospital to reinforce the efficacy of universal hereditary cancer genetic testing for all breast cancer patients, regardless of their location. The study found that a majority of patients benefited from the knowledge gained from testing, and this influenced their treatment decisions. The results also suggest that adopting such testing universally can optimize care and reduce unnecessary utilization of healthcare resources.
Group-IB’s Threat Intelligence and Defence Centre Equip Undergraduates with Sophisticated Cybersecurity Technologies to Boost Threat Analysis and Enhance Cyber Resilience for Campus Start-ups
Hey there from the heart of the San Francisco Bay Area! It’s an absolute pleasure to have you back again for our chat on some
